Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3
出版年份 2013 全文链接
标题
Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3
作者
关键词
-
出版物
Cell Death & Disease
Volume 4, Issue 6, Pages e655-e655
出版商
Springer Nature
发表日期
2013-06-06
DOI
10.1038/cddis.2013.192
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
- (2013) Meghna Das Thakur et al. NATURE
- TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1
- (2013) D M Moujalled et al. Cell Death & Disease
- Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1
- (2012) ZhenZhen Zhan et al. Autophagy
- The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance
- (2012) D. Wroblewski et al. CARCINOGENESIS
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
- (2012) Liming Sun et al. CELL
- The Mitochondrial Phosphatase PGAM5 Functions at the Convergence Point of Multiple Necrotic Death Pathways
- (2012) Zhigao Wang et al. CELL
- BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma
- (2012) Y Shao et al. CELL DEATH AND DIFFERENTIATION
- Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models
- (2012) P Vandenabeele et al. CELL DEATH AND DIFFERENTIATION
- The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms
- (2012) K. H. T. Paraiso et al. CLINICAL CANCER RESEARCH
- The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
- (2012) T. Shimizu et al. CLINICAL CANCER RESEARCH
- Melanoma: New Insights and New Therapies
- (2012) Vasiliki A. Nikolaou et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- NF-κB as potential target in the treatment of melanoma
- (2012) Gabriele Madonna et al. Journal of Translational Medicine
- Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET ONCOLOGY
- Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
- (2012) Jeffrey R Infante et al. LANCET ONCOLOGY
- Vemurafenib: the first drug approved for BRAF-mutant cancer
- (2012) Gideon Bollag et al. NATURE REVIEWS DRUG DISCOVERY
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models
- (2012) N Takahashi et al. Cell Death & Disease
- NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-α Feedforward Signaling
- (2011) Sharon Biton et al. CELL
- PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
- (2011) Ganta Chaitanya et al. Cell Communication and Signaling
- Many stimuli pull the necrotic trigger, an overview
- (2011) N Vanlangenakker et al. CELL DEATH AND DIFFERENTIATION
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress
- (2011) L Dong et al. ONCOGENE
- RIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation
- (2011) YoungSik Cho et al. PLoS One
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- MEK-Independent Survival of B-RAFV600E Melanoma Cells Selected for Resistance to Apoptosis Induced by the RAF Inhibitor PLX4720
- (2010) C. C. Jiang et al. CLINICAL CANCER RESEARCH
- Necroptosis as an alternative form of programmed cell death
- (2010) Dana E Christofferson et al. CURRENT OPINION IN CELL BIOLOGY
- A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors
- (2010) Mark Andrew Dickson et al. INVESTIGATIONAL NEW DRUGS
- Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032
- (2010) Jonas N Søndergaard et al. Journal of Translational Medicine
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Melanoma — An Unlikely Poster Child for Personalized Cancer Therapy
- (2010) Keiran S.M. Smalley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS
- (2010) C C Jiang et al. Cell Death & Disease
- A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma
- (2009) A Rocca et al. BRITISH JOURNAL OF CANCER
- Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
- (2009) D. D. Vo et al. CANCER RESEARCH
- Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
- (2009) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma
- (2009) Axel Hauschild et al. MELANOMA RESEARCH
- MEK1 mutations confer resistance to MEK and B-RAF inhibition
- (2009) C. M. Emery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway
- (2008) Junichi Hitomi et al. CELL
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started